Skip to main content
9 articles related to "Nh36"

Articles

Original Research

Published on 12 Jul 2017

F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis

in Vaccines and Molecular Therapeutics

  • Eugenia Carrillo
  • Laura Fernandez
  • Ana Victoria Ibarra-Meneses
  • Micheli L. B. Santos
  • Dirlei Nico
  • Paula M. de Luca
  • Cristiane Bani Correa
  • Roque Pacheco de Almeida
  • Javier Moreno
  • Clarisa B. Palatnik-de-Sousa
Frontiers in Immunology
doi 10.3389/fimmu.2017.00750
  • 4,183 views
  • 16 citations

Original Research

Published on 31 Mar 2025

Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis

in Vaccines and Molecular Therapeutics

  • Aline Silva Barreto
  • Mariana Nobre Farias de Franca
  • Tatiana Leão dos Santos dos Reis
  • Joao Antonio Barbosa Martins Silva
  • Priscila Lima Dos Santos
  • Fabrícia Alvisi de Oliveira
  • Angela Maria da Silva
  • Lucas Sousa Magalhaes
  • Danielle Angst Secco
  • Maria Aiza Fontes Andrade
Frontiers in Immunology
doi 10.3389/fimmu.2025.1540537
  • 4,246 views
  • 5 citations

Original Research

Published on 07 May 2018

NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis

in Vaccines and Molecular Therapeutics

  • Dirlei Nico
  • Fernanda Martins Almeida
  • Juliana Maria Motta
  • Fellipe Soares dos Santos Cardoso
  • Celio Geraldo Freire-de-Lima
  • Leonardo Freire-de-Lima
  • Paula Melo de Luca
  • Ana Maria Blanco Martinez
  • Alexandre Morrot
  • Clarisa Beatriz Palatnik-de-Sousa
Frontiers in Immunology
doi 10.3389/fimmu.2018.00967
  • 43,362 views
  • 11 citations